Pyridine → 3-[(4S)-4-amino-5-ethoxy-5-oxopentanamido]-5-chloro-2-hydroxybenzene-1-sulfonic acid
반응식
CN(C(ON1N=[N:16][C:11]2[CH:12]=[CH:13][CH:14]=[N:15][C:10]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=NC2N([OH:34])N=NC=2C=1.NC1[C:37]([OH:47])=[C:38]([S:43]([OH:46])(=[O:45])=[O:44])[CH:39]=[C:40]([Cl:42])[CH:41]=1.N1[CH:53]=[CH:52]C=CC=1.[C:54]([OH:60])(C(F)(F)F)=[O:55]>CN(C=O)C>[NH2:16][C@H:11]([C:54]([O:60][CH2:52][CH3:53])=[O:55])[CH2:12][CH2:13][C:14]([NH:15][C:10]1[C:37]([OH:47])=[C:38]([S:43]([OH:46])(=[O:44])=[O:45])[CH:39]=[C:40]([Cl:42])[CH:41]=1)=[O:34]참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
After 92 mg (0.33 mmol) of the compound obtained in Step 1, 130 mg (0.33 mmol) of HATU, 45 mg (0.33 mmol) of HOAt and 77 mg (0.33 mmol) of 3-amino-5-chloro2-hydroxybenzenesulfonic acid were suspended in 1.0 ml of DMF, 0.25 ml of pyridine was added to the suspension. The mixture was stirred at room temperature overnight. The solvent was removed by distillation and the mixture was purified in accordance with the purification step A to give the intermediate. The crude product was dissolved in 4.0 ml of TFA. The solution was stirred at room temperature for an hour. The solvent was removed by distillation and the mixture was purified in accordance with the purification step A to give 47.2 mg of the title compound.
후처리
- customThe solvent was removed by distillation
- customthe mixture was purified in accordance with the purification step A
- customto give the intermediate
- stirringThe solution was stirred at room temperature for an hour
- customThe solvent was removed by distillation
- customthe mixture was purified in accordance with the purification step A
출처 및 근거
- ORD 기록
- ord-64343dd915bd4ddc917e9314ddae75ac
- 출처 데이터셋
- uspto-grants-2014_11
- 특허 번호
- US08877739B2
반응 노트
불러오는 중…